What Does Align Technology (ALGN) Do? - Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Summary
Align Technology (ALGN) is a US dental medical-device company that supplies clear aligners and intraoral scanners, and is considered a stock where adult orthodontic demand, emerging-market expansion, and the shift to digital dentistry via intraoral scanners, along with consumer-cycle trends, are key drivers for earnings and share-price outlook.
Subscribe🏢 What kind of company is Align Technology?
Align Technology (ALGN) is a US dental medical-device company that makes Invisalign clear aligners and intraoral scanners. It pioneered the segment of straightening teeth with transparent plastic devices rather than wire braces, and also supplies equipment that digitally scans the oral cavity.
The business is divided into two main pillars: clear aligners and intraoral scanners/software. Clear aligners are delivered to patients through dentists and orthodontic specialists, accounting for a large share of revenue, while intraoral scanners serve as the entry point to the digital-dental workflow. The growth foundation is built on demand for orthodontic treatment, emerging-market expansion, and the digitalization of dental practices.
💰 How does Align Technology make money?
| Business Segment | Revenue Share | Description |
|---|---|---|
| Clear Aligners | Core | The core segment, led by Invisalign and other clear aligners, accounting for a large share of revenue |
| Intraoral Scanners & Software | Expanding | Intraoral scanners and digital-dentistry software segment |
| Emerging Markets & Adult Orthodontics | Growth Driver | Expansion in emerging markets and adult orthodontic demand |
Clear aligners account for the largest share of Align Technology's revenue, with intraoral scanners and software complementing it. Growing interest in aesthetics and health is driving demand for adult orthodontics, while emerging-market expansion and the shift to digital dentistry provide a structural growth foundation. However, orthodontic treatment is a costly discretionary purchase, making it sensitive to economic cycles, and competitor entry and pricing pressure are variables to watch. The company is pursuing growth through new product launches, expansion of its doctor network, and entry into emerging markets.
📐 Align Technology market cap and company scale
Market capitalization stands at $10.7B, and employee headcount is 20,290 people.
As a global dental medical-device company that pioneered the clear aligner field, it owns a digital-dentistry ecosystem spanning Invisalign and intraoral scanners/software. Leveraging the structural demand for clear aligners and the shift to digital dentistry as strengths, the company is in a phase of growth driven by emerging-market expansion and adult orthodontic demand.
📈 Align Technology outlook and share-price trends
1-Year Price Performance
Analyst Consensus
52-Week Price RangeAdult orthodontic demand driven by aesthetic and health interest, emerging-market expansion, and the shift to digital dentistry are medium- to long-term drivers. Penetration of clear aligners remains low, leaving significant room for growth, and the digitalization of dental practices through intraoral scanners is expanding the ecosystem. New product launches and expansion of the doctor network are also contributing to growth. However, given the discretionary nature of orthodontic treatment, consumer-spending slowdowns, competitor entry and pricing pressure, and currency fluctuations can act as short-term earnings variables.
- Growth potential from adult orthodontic demand and low clear-aligner penetration
- Emerging-market expansion
- Shift to digital dentistry through intraoral scanners
⚔️ Align Technology core competitive strengths and risks
Clear-aligner leadership, a digital-dentistry ecosystem, and growth potential from low penetration are strengths, while consumer-cycle sensitivity, competitive and pricing pressure, and currency exposure are the core risks.
💪 Core Competitive Strengths
⚠️ Core Risks
🔄 Align Technology competitors and related (beneficiary) stocks
Align Technology, operating in the dental medical-device space, is compared alongside other dental and medical-device companies. Dental equipment and supplies player XRAY and medical-device company SOLV are frequently cited as comparables in terms of business area and dental/medical demand.
Competitors| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
 XRAY | DENTSPLY Sirona Inc | $10.46 | -0.4% | $2.1B | - | 1.5 | -32.98% | 0.61% |
 SOLV | Solventum Corp | $87.45 | -0.2% | $14.9B | 10.7 | 3.1 | 33.96% | - |
✅ Align Technology investor checklist
Align Technology is a US dental medical-device company supplying clear aligners and intraoral scanners. Its clear-aligner leadership and digital-dentistry ecosystem are appealing, but investors should also weigh consumer-cycle sensitivity and competitive/pricing pressure.
| Checklist | What to Confirm | Current Status |
|---|---|---|
| 😁 Clear Aligner Demand | Adult orthodontic demand and clear-aligner penetration | Core growth driver |
| 🌏 Emerging Markets & Digital | Emerging-market expansion and intraoral scanner-driven digital shift | Growth engine |
| 📉 Consumer & Competition | Consumer-cycle sensitivity and competitive/pricing pressure | Volatility factor |
Given the discretionary nature of orthodontic treatment, consumer-spending slowdowns, competitor entry and pricing pressure, and currency fluctuations can impact earnings, so it is worth monitoring clear-aligner demand alongside emerging-market and digital-dentistry expansion.
Align Technology is a US dental medical-device company equipped with clear-aligner leadership, a digital-dentistry ecosystem, and the growth potential of low penetration. However, factoring in consumer-cycle sensitivity, competitive and pricing pressure, and currency variables, a medium- to long-term investment perspective is advisable.
Subscribe Today's 5 AI picks, all free